Vancouver, BC, Canada - February 27, 2019 - Aspect Biosystems, a Vancouver biotech company pioneering microfluidic 3D bioprinting of human tissues, has been named 2019 Growth Stage Company of the Year by LifeSciences BC. The LifeSciences BC Annual Awards, presented by FARRIS, recognizes talented individuals and organizations that represent the life sciences ecosystem in BC which includes academia, health institutions, government and industry.
Aspect has experienced rapid growth and demonstrated strong commercial traction since spinning out of the University of British Columbia. Over the past three years, the company has grown from less than 10 to over 35 employees, brought in smart venture capital to fuel development and expansion, and partnered with global pharmaceutical, biotechnology, and advanced materials companies, as well as academic researchers. Innovating at the cutting-edge of science, medicine, and engineering, Aspect has become a globally recognized leader in the field of 3D bioprinting and regenerative medicine.
“We are very humbled to be recognized by scientific and biotech leaders in the life sciences community for such a prestigious award,” said Tamer Mohamed, chief executive officer, Aspect Biosystems. “Every day, our team is moving the needle closer towards a future where patients can be treated with 3D printed living tissue therapeutics. With world-class scientific and medical innovation and a bold entrepreneurial spirit, British Columbia is uniquely positioned to deliver meaningful global impact, and Aspect is deeply committed to contributing to this collective effort. Congratulations to all the winners who represent the best of what BC has to offer.”
Full list of 2019 LifeSciencesBC Award Winners:
The 2019 LifeSciencesBC award winners will be recognized at the 21st Annual LifeSciences BC Awards Dinner, presented by FARRIS, on Thursday, April 4, 2019 at the Vancouver Convention Centre West.
This award comes on the back of Aspect being named Emerging Company of the Year in 2018 by BIOTECanada.
LifeSciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry.
Life sciences sectors, from biopharmaceuticals and medical technology, to digital health and medical devices, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Aspect Biosystems is a privately held biotechnology company pioneering microfluidic 3D bioprinting of living, human tissue. The company’s proprietary technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.
Natalie Korenic, Marketing & Communications Manager